Quick Answer
PharmaCyte Biotech, Inc. reported Gross Profit of $0.00 for fiscal year 2016.
PharmaCyte Biotech, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2016 | $0.00 | — |
| 2015 | $0.00 | — |
| 2014 | $0.00 | -100.0% |
| 2013 | $2.5K | -94.6% |
| 2012 | $47.2K | -49.8% |
| 2011 | $93.9K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| October 31, 2016 | $0.00 | — | — |
| January 31, 2016 | $0.00 | — | — |
| October 31, 2015 | $0.00 | — | — |
| July 31, 2015 | $0.00 | — | — |
| January 31, 2015 | $0.00 | — | — |
| October 31, 2014 | $0.00 | — | — |
| July 31, 2014 | $0.00 | — | — |
| January 31, 2014 | $0.00 | — | — |
- Over the 2011–2016 period, PharmaCyte Biotech, Inc.’s gross profit has declined by 100.0% (from $93.9 thousand to $0.00).
- The most recent figure is from PharmaCyte Biotech, Inc.’s fiscal year 2016 report (Form 10-K), filed with the SEC on July 29, 2016.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: